Immunoassay (1)Research report published by Proficient Market Research “Immunoassay Market, By Type (Enzyme Immunoassay (EIA), Radioimmunoassay (RIA), Fluoroimmunoassay (FIA), Chemiluminescent Immunoassay (CLIA) and Counting Immunoassay (CIA)); By Application (Infectious Diseases, Oncology, Blood Screening, Cardiology and Others) Market – Growth, Future Prospects, Post COVID-19 Scenario 2020 – 2028”,states that the global Immunoassay is expected to grow at a CAGR of 6.8% during the forecast period from 2021 to 2028.

Rising prevalence of various chronic diseases and need for their diagnosis as early as possible is prevailing the requirement of immunoassays test. Increasing instances of cancer is elevating the need for an individual to test for preventing further damage in the body. Also, Immunoassays are being highly used to detect COVID-19 as well as other infectious diseases which are on the rise and hence in order to control the spread of virus these tests along with many other are carried out.

Browse the full report: https://proficientmarket.com/report/1463/global-immunoassay-market

Download Full Summary @ https://proficientmarket.com/sample/1463

Thereby these factors are expected to increase the growth as well as the disposable income of the market globally.

Several applications of immunoassay include infectious diseases, oncology, blood screening, cardiology, etc. Among the applications, infectious diseases held the largest market share in past years owing to prevailing covid-19 globally and other infectious diseases which remain undiagnosed, eventually growing the demand of immunoassays.

Browse in-depth TOC on “Immunoassay Market” @ https://proficientmarket.com/report/1463/global-immunoassay-market#toc

Direct Purchase @ https://proficientmarket.com/checkout/1463/1ecda5z5e4

Market Players

Some of the prominent players of the market include Danaher Corp., Thermo Fisher Scientific company, Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Quidel Corporation., DiaSorin S.p.A, bioMérieux SA, Bio-Rad Laboratories, Inc. and Ortho-Clinical Diagnostics, Inc.

Leading companies operating in the immunoassay manufacturing are working towards improving the quality of tests so that the tests can be carried out in minimum time.

Trends and Future Outlook:

Creative Diagnostics has developed new immunoassay kit that is designed specifically to detect corona virus as well as the antibodies that can fight against COVID-19.

Grab Report Sample @ https://proficientmarket.com/sample/1463

Based on type, the immunoassay market is segmented into the following:

Enzyme Immunoassay (EIA)
Radioimmunoassay (RIA)
Fluoroimmunoassay (FIA)
Chemiluminescent Immunoassay (CLIA)
Counting Immunoassay (CIA)

Enzyme Immunoassay (EIA) segment led the overall immunoassay market in terms of market value

In 2020, the enzyme immunoassay segment led the overall immunoassay market in terms of market value. As immunoassay process requires an antibody connected to an enzyme, it helps in efficient viewing and quantifying the antigens, therefore attaching to the antigen making the process undemanding.

Request For Discount Pricing @ https://proficientmarket.com/buying-request/1463

Based on application, the immunoassay market is segmented into following:

Infectious Diseases
Oncology
Blood Screening
Cardiology
Others

Infectious Diseases segment led the overall immunoassay market in terms of market value

In 2020, the infectious diseases segment led the overall immunoassay market in terms of market value. Due to increasing number of unidentifiable diseases, outbreak of COVID-19 and various other such outbreaks are propelling the need for diagnosis and in depth study of the disease thereby, accelerating the growth of immunoassay market.

Request For Full Segment Analysis @ https://proficientmarket.com/sample/1463

North America held the largest share in the immunoassay market

In 2020, North America accounted for the largest share in the immunoassay market due to presence of well-established healthcare companies, increased number of infectious diseases, increasing spending of the government towards healthcare and research and increased adoption of people towards various tests to keep themselves away from diseases.

Request For Any Specific Customization @ https://proficientmarket.com/customization-request/1463

Related Reports:
https://proficientmarket.com/report/1471/global-sterilization-equipment-market
https://proficientmarket.com/report/1465/global-oxygen-therapy-market

About Us:

Proficient Market is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialist with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market. Our happiness is when we help our clients grow their business, strengthen the brands and educate their members or consumers through the ever new fun research methods developed by our team.

Contact Us:

Proficient Market
1st Floor, Harikrishna Building,
Samarth Nagar, New Sanghvi,
Pune- 411027 India
Tel: +91-8149441100 (GMT Office Hours)
USA: +17738002974
Email: sales@proficientmarket.com
Web: proficientmarket.com

See Campaign: https://proficientmarket.com/report/1463/global-immunoassay-market
Contact Information:
Proficient Market 1st Floor, Harikrishna Building, Samarth Nagar, New Sanghvi, Pune- 411027 India Tel: +91-8149441100 (GMT Office Hours) USA: +17738002974 Email: sales@proficientmarket.com Web: proficientmarket.com

Tags:
Reportedtimes, IPS, Financial Content, iCN Internal Distribution, Extended Distribution, Research Newswire, English

image

Contact Information:

Proficient Market
1st Floor, Harikrishna Building,
Samarth Nagar, New Sanghvi,
Pune- 411027 India
Tel: +91-8149441100 (GMT Office Hours)
USA: +17738002974
Email: sales@proficientmarket.com
Web: proficientmarket.com

The post Immunoassay Market is expected to grow at a CAGR of 6.8% from 2020 to 2028 | Rising Public Health Safety Concerns Along with Increasing Number of Diseases is Elevating the Need for Immunoassay appeared first on Financial Market News.